Impact of perioperative probiotic treatment for surgical site infections in patients with colorectal cancer

Experimental and Therapeutic Medicine

Volumn 10, Issue 3, 2015, Pages 966-972

  Aisu, Naoya ^a   Tanimura, Shu ^a   Yamashita, Yuichi ^a   Yamashita, Kanefumi ^a   Maki, Kenji ^a   Yoshida, Yoichiro ^a   Sasaki, Takamitsu ^a   Takeno, Shinsuke ^a   Hoshino, Seiichiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Colorectal cancer surgery; ImmuKnow; Probiotics; Surgical site infections; Terminal restriction fragment length polymorphism

Indexed keywords

ADENOSINE TRIPHOSPHATE; CEFMETAZOLE; PROBIOTIC AGENT;

AGED; ARTICLE; CD4+ T LYMPHOCYTE; COLORECTAL CANCER; CONTROLLED STUDY; DRUG SAFETY; FECES MICROFLORA; FEMALE; HUMAN; IMMUNE CELL FUNCTION ASSAY; IMMUNE RESPONSE; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SURGICAL INFECTION;

EID: 84937716692     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2640     Document Type: Article

References (26)

1. Kusachi S, Kashimura N, Konishi T, et al: Length of stay and cost for surgical site infection after abdominal and cardiac surgery in Japanese hospitals: multi-center surveillance. Surg Infect (Larchmt) 13: 257-265, 2012.
2. Mangram AJ, Horan TC, Pearson ML, et al: Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 20: 250-280, 1999.
3. Takesue Y, Kusunoki M, Kobayashi M, et al: The prevalence of surgical site infection (SSI) by the introduction of the best practice in the perioperative management and operative manipulation; multi-center prospective study of 1601 colorectal patients. Nihon Geka Kansensho Gakkai Zasshi 3: 471-476, 2006 (In Japanese).
4. Rafter J: The effects of probiotics on colon cancer development. Nutr Res Rev 17: 277-284, 2004.
5. Wang T, Cai G, Qiu Y, et al: Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 6: 320-329, 2012.
6. Eguchi S, Takatsuki M, Hidaka M, et al: Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: a prospective randomized study. Am J Surg 201: 498-502, 2011.
7. Nagashima K, Hisada T, Sato M and Mochizuki J: Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial populations in human feces. Appl Environ Microbiol 69: 1251-1262, 2003.
8. Kowalski R, Post D, Schneider MC, et al: Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant 17: 77-88, 2003.
9. Onodera T, Goseki N, Kosaki G: Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 85: 1001-1005, 1984 (In Japanese).
10. Nakamura T, Kashimura N, Noji T, et al: Triclosan-coated sutures reduce the incidence of wound infections and the costs after colorectal surgery: a randomized controlled trial. Surgery 153: 576-583, 2013.
11. Itani KM, Wilson SE, Awad SS, et al: Ertapenem versus cefotetan prophylaxis in elective colorectal surgery. N Engl J Med 355: 2640-2651, 2006.
12. Serra-Aracil X, García-Domingo MI, Parés D, et al: Surgical site infection in elective operations for colorectal cancer after the application of preventive measures. Arch Surg 146: 606-612, 2011.
13. Young H, Knepper B, Moore EE, et al: Surgical site infection after colon surgery: National Healthcare Safety Network risk factors and modeled rates compared with published risk factors and rates. J Am Coll Surg 214: 852-859, 2012.
14. Tanaka K, Yano M, Motoori M, et al: Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy: a prospective randomized controlled trial. Surgery 152: 832-842, 2012.
15. Sugawara G, Nagino M, Nishio H, et al: Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg 244: 706-714, 2006.
16. Zhang JW, Du P, Gao J, et al: Preoperative probiotics decrease postoperative infectious complications of colorectal cancer. Am J Med Sci 343: 199-205, 2012.
17. Kanazawa H, Nagino M, Kamiya S, et al: Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg 390: 104-113, 2005.
18. Sheih YH, Chiang BL, Wang LH, et al: Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J Am Coll Nutr 20 (2 Suppl): 149-156, 2001.
19. Matsuzaki T and Chin J: Modulating immune responses with probiotic bacteria. Immunol Cell Biol 78: 67-73, 2000.
20. Huang YF, Liu PY, Chen YY, et al: Three-combination probiotics therapy in children with salmonella and rotavirus gastroenteritis. J Clin Gastroenterol 48: 37-42, 2014.
21. Bar t osch S, Woodmansey EJ, Pat erson JC, et al: Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clin Infect Dis 40: 28-37, 2005.
22. Mitsuoka T: Significance of dietary modulation of intestinal flora and intestinal environment. Biosci Microflora 19: 15-25, 2000.
23. Willemsen LE, Koetsier MA, van Deventer SJ and van Tol EA: Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts. Gut 52: 1442-1447, 2003.
24. Kowalski RJ, Post DR, Mannon RB, et al: Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation 82: 663-668, 2006.
25. Sheeran P and Hall GM: Cytokines in anaesthesia. Brit J Anaesth 78: 201-219, 1997.
26. Duc le H, Hong HA, Barbosa TM, et al: Characterization of Bacillus probiotics available for human use. Appl Environ Microbiol 70: 2161-2171, 2004.